PTN

General Information


DRACP ID  DRACP01059

Peptide Name   PTN

Sequence  ILGTILGLLKGL

Sequence Length  12

UniProt ID  Not available

PubChem CID  Not available

Origin  venom glands of three different wasps

Type  Native peptide

Classification

  

Active ACP Cancer targeted peptides



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
MDA-MB-231 Breast adenocarcinoma Carcinoma CC50=15.9±1.1 µM MTT assay 24h 1

Hemolytic Activity  hRBC(human blood red cells): CC50>>500 µM

Normal (non-cancerous) Cytotoxicity  MCF-10A : CC50=96.8±3.5 µM (testing time is 24 h)

Target  lipids

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  DRACP01059

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C58H107N13O14

Absent amino acids  ACDEFHMNPQRSVWY

Common amino acids  L

Mass  140698

Pl  9.7

Basic residues  1

Acidic residues  0

Hydrophobic residues  7

Net charge  1

Boman Index  2914

Hydrophobicity  185

Aliphatic Index  227.5

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  4

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 34090029

Title  Protonectin peptides target lipids, act at the interface and selectively kill metastatic breast cancer cells while preserving morphological integrity

Doi 10.1016/j.jcis.2021.05.115

Year  2021

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.